Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Greenrise Global Brands Inc. (C:XCX)

Business Focus: Alternative Medicine

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for XCX within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Aug 08, 2022 03:00 ET
Greenrise Announces Record Sales for Q2 and Comments on Positive Developments regarding the Legislation of Adult-Use Cannabis in Germany
VANCOUVER, BC and HAMBURG, Germany, Aug. 8, 2022 /CNW/ - Greenrise Global Brands Inc. (Frankfurt: C4T) (ISIN: CA39540L1085) (CSE: XCX) ("Greenrise" and "the Company") is pleased to provide preliminary, unaudited second quarter financial results for the three months ending June 30, 2022 ("Q2") and commentary on recent developments in the adult use of cannabis legislation in Germany.
Read full article
Jun 20, 2022 03:00 ET
Greenrise Provides Update on CannaCare's Sales Growth and First Quarter Results
HAMBURG, GERMANY, June 20, 2022 /CNW/ - Greenrise Global Brands Inc. (Frankfurt: C4T) (ISIN: CA39540L1085) (CSE: XCX) ("Greenrise"), which operates in the German CBD wellbeing and medical cannabis market announces its results for the three months ending March 31st, 2022 (Q1, 2022) and provides an update about the acquisition of CannaCare Health GmbH ("CannaCare").
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
-0.08
--
--
Price to Sales - TTM
--
2.44
3.46
Price to Book - most recent quarter
--
1.07
2.02
Price to Cash Flow per share - TTM
--
--
9.70
Price to Free Cash Flow per share - TTM
--
7.24
12.33
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Feb 29, 20241,164567
Feb 15, 2024597549
Jan 31, 202448-2
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Greenrise Global Brands Inc. is a Canada-based investment holding company with investments in the cannabis industry in Germany. The Company, through CannaCare Health GmbH (CannaCare), offers a range of approximately 20 cannabidiol (CBD) products consisting of tinctures, sprays and oils and skincare products made from natural raw materials manufactured in Europe and Germany and distributed through traditional sales channels, such as www.cannacare-health.com and www.canobo.de. CannaCare is a producer and supplier of CBD wellness products and wholly owns AMP Alternative Medical Products GmbH (AMP), an importer and distributor of European Union-Good Manufacturing Practice (EU-GMP) medical cannabis to pharmacies.

See business summary

 

Twitter

Search (past week) for $XCX.CA

  • No tweets found